Has Kenneth Lyn Kew, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,655 in general payments to Kenneth Lyn Kew, MD across 46 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kenneth Lyn Kew, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kenneth Lyn Kew, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kenneth Lyn Kew, MD

Critical Care Medicine · Denver, CONPI 1154441533

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,286 of the $3,655 with a category attached, or 89.9%. 7 manufacturers reported payments, led by Abiomed at 51.0% of the total.

$3,655in general payments, 2019–2025

Across 46 payments — averaging $79.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$2K
Inari Medical, Inc.$692
Livanova USA, Inc.$677
La Jolla Pharmaceutical Company$245
Stryker$112
Edwards Lifesciences$40
plus $24 from 1 others

What the payments were for

Travel & lodging$36910%
Food & beverage$3,28690%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	27	$1,864
Inari Medical, Inc.	6	$692
Livanova USA, Inc.	7	$677
La Jolla Pharmaceutical Company	3	$245
Stryker	1	$112
Edwards Lifesciences	1	$40
Abbott	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,655 in reported general payments places this provider in the 80th percentile of 141 critical care medicine providers in Colorado.

See all critical care medicine providers in Colorado →

Medicare billing

Part B allowed, 2024

$27,753

Medicare patients

Services billed

161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Denver

Gregory CosgroveDenver$46K
Walter ConwellDenver$42K
David HsiaDenver$38K
Jennifer Faber GerlingDenver$30K
Ivor DouglasDenver$24K
Edward ChanDenver$6K
Ikue NakayamaDenver$3K
Andi HudlerDenver$2K
Patrick HumeDenver$1K
Anuj MehtaDenver$888

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →